Assignee
TURNING POINT THERAPEUTICS INC
US·18 granted patents·13 pending applications·30 citations·filing 2015–2025
Top patents by PatentIndex Score
31 records- 0195US11155563B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·3 cites·3 claims
- 0294US10745416B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Aug 18, 2020·4 cites·29 claims
- 0393US10618912B2Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Apr 14, 2020·5 cites·19 claims
- 0492US11142533B2Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2021·Granted Oct 12, 2021·2 cites·3 claims
- 0592US10689400B2Macrocycle kinase inhibitorsTURNING POINT THERAPEUTICS INC·Filed 2017·Granted Jun 23, 2020·7 cites·19 claims
- 0691US12187739B2Diaryl macrocycle polymorphTURNING POINT THERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·1 cites·23 claims
- 0791US11981684B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·1 cites·20 claims
- 0891US11286264B2Macrocyclic compounds and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Mar 29, 2022·4 cites·21 claims
- 0986US2025223298A1Diaryl macrocycle polymorphTURNING POINT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1085US11452725B2Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·1 cites·20 claims
- 1184US11634433B2Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·1 cites·17 claims
- 1283US12404281B2Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·7 claims
- 1379US12310968B2Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2022·Granted May 27, 2025·0 cites·27 claims
- 1477US11291667B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·15 claims
- 1577US2025375451A1Chiral diaryl macrocycles and uses thereofTURNING POINT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1677US2022112213A1Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1775US2023322806A1Macrocycles for use in treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1875US2021094974A1Diaryl macrocycle polymorphTURNING POINT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1972US2022306652A1Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2071US11286265B2Macrocyclic compounds for treating diseaseTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·0 cites·15 claims
- 2170US2020216465A1Diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2269US2024033266A1Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2367US2023398119A1Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2463US11654145B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·0 cites·30 claims
- 2562US11666574B2Combination therapy involving diaryl macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2020·Granted Jun 6, 2023·0 cites·17 claims
- 2661USRE50634EDiaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2015·Granted Oct 14, 2025·0 cites·24 claims
- 2760US2025002505A1Synthesis of macroyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2855US2025262216A1Therapeutic uses of macrocyclic compoundsTURNING POINT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2954US11008337B2Chiral diaryl macrocycles as modulators of protein kinasesTURNING POINT THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·0 cites·22 claims
- 3045US2021087206A1Macrocyclic kinase inhibitors and their useTURNING POINT THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3143US2022411439A1Polymorphs of a macrocyclic kinase inhibitorTURNING POINT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TURNING POINT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →